Letter to the editor regarding "urate-lowering therapy for patients with gout on hemodialysis"
Int J Rheum Dis
.
2023 Jan;26(1):177-178.
doi: 10.1111/1756-185X.14469.
Epub 2022 Oct 17.
Authors
Yung-Shun Tsai
1
,
Yung-Heng Lee
2
3
4
5
,
Meng-Yu Ko
6
7
Affiliations
1
School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
2
Department of Orthopedics, Cishan Hospital, Ministry of Health and Welfare, Kaohsiung, Taiwan.
3
Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung, Taiwan.
4
Department of Senior Services Industry Management, Minghsin University of Science and Technology, Hsinchu, Taiwan.
5
Department of Recreation and Sport Management, Shu-Te University, Kaohsiung, Taiwan.
6
Division of Gastroenterology and Hepatology, Changhua Christian Hospital, Changhua, Taiwan.
7
Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
PMID:
36250780
DOI:
10.1111/1756-185X.14469
No abstract available
Publication types
Letter
Comment
MeSH terms
Gout Suppressants / adverse effects
Gout* / diagnosis
Gout* / drug therapy
Humans
Renal Dialysis / adverse effects
Uric Acid*
Substances
Uric Acid
Gout Suppressants